These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6219628)

  • 1. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 2. Decline of plasma concentrations of etretinate and its main metabolite after treatment.
    Lauharanta J; Paravicini U; Kanerva L; Lassus A
    Arch Dermatol Res; 1982; 274(3-4):377-9. PubMed ID: 7165382
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
    Larsen FG; Jakobsen P; Eriksen H; Grønhøj J; Kragballe K; Nielsen-Kudsk F
    J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670).
    Ishizaki H; Masuda H; Kaseda H; Kaminaga T; Hirone T
    J Dermatol; 1983 Oct; 10(5):421-6. PubMed ID: 6230381
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of route of administration on the pharmacokinetics of etretinate in the dog.
    Bornemann LD; Cotler S; Khoo KC; Carbone JJ; Colburn WA
    Biopharm Drug Dispos; 1988; 9(1):119-26. PubMed ID: 2963666
    [No Abstract]   [Full Text] [Related]  

  • 7. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 9. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
    Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F
    J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A; Rollman O; Pihl-Lundin I
    Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
    Thongnopnua P; Zimmerman CL
    J Chromatogr; 1988 Dec; 433():345-51. PubMed ID: 2976770
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly discovered xenobiotic metabolic pathway: ethyl ester formation.
    Chou RC; Wyss R; Huselton CA; Wiegand UW
    Life Sci; 1991; 49(21):PL169-72. PubMed ID: 1834900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
    Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.